Mouse embryonic mesenchymal cells undergo spontaneous smooth muscle (SM) differentiation upon spreading/elongation in culture (Relan et al., J. Cell Biol. 147 (1999) 1341 Yang et al., Development 125 (1998) 2621 Yang et al., Development 126 (1999) 3027). Using these cells we generated a subtracted cDNA library to identify potential suppressors of SM myogenesis. One of the differentially expressed genes was heterogeneous nuclear ribonucleoprotein-H (hnRNP-H), which is involved in pre-mRNA alternative splicing. hnRNP-H was highly expressed in mesenchymal cells prior to the onset of SM differentiation, but its expression rapidly decreased in mesenchymal cells undergoing SM myogenesis. In vivo, the drop in hnRNP-H expression was restricted to visceral SM cells. Antisense oligodeoxynucleotide and antisense RNA were used to inhibit hnRNP-H synthesis in SM-differentiating mesenchymal cells and in embryonic lung explants. A decrease in hnRNP-H levels resulted in upregulation of SM-speci®c gene expression and increased bronchial SM development in lung explants. hnRNP-H overexpression in cell cultures had the opposite effect. These studies, therefore, indicate a novel role for hnRNP-H in the control of visceral myogenesis. q
Introduction
Smooth muscle (SM) comprises a signi®cant portion of developing organs including those of the gastrointestinal, urogenital and respiratory tracts, and the vascular system. Most SM originates by differentiation of local mesenchymal cells, which in mid-gestation begin to express and accumulate SM proteins (Ruzicka and Schwartz, 1988; Sawtell and Lessard, 1989; Kedinger et al., 1990; Roman and McDonald, 1992; McHugh, 1995; Li et al., 1996) in a process that progresses in a cranial to caudal gradient. With the exception of the aorta, the appearance of visceral SM a-actin, desmin and myosin precedes that of the vascular musculature Woodcock-Mitchell et al., 1993; Miano et al., 1994; McHugh, 1995) . SM a-actin and muscle myosin appear earlier than desmin (Lazarides and Capetanaki, 1986; Mitchell et al., 1990) , and it has been suggested that SM a-actin may be a marker for initial SM differentiation, whereas desmin may indicate a state of terminal differentiation . In contrast to the previous proteins, transcripts of SM22, another SM-speci®c marker, are ®rst expressed in vascular SM cells (Li et al., 1996) .
In the developing mouse lung, SM a-actin (Roman and McDonald, 1992) and corresponding mRNA (McHugh, 1995) are ®rst detected on day 11 of gestation in the trachea and proximal segments of the main bronchi, along with transcripts for muscle myosin and SM22 (Miano et al., 1994; Li et al., 1996) . The last two also are detected in the proximal segments of pulmonary arteries (Miano et al., 1994; Li et al., 1996) . The non-bronchovascular lung mesenchyme does not express SM proteins at any time during embryogenesis (Woodcock-Mitchell et al., 1993; Miano et al., 1994; McHugh, 1995; Li et al., 1996) . However, in the postnatal lung, some of the mesenchymal cells become contractile interstitial cells or alveolar myo®-broblasts (Kapanchi et al., 1974) and express SM a-actin .
Although our understanding of SM biology has grown considerably over the years, the molecular mechanisms that induce SM differentiation remain largely unknown. Undifferentiated embryonic mesenchymal cells are potential SM cell precursors that undergo spontaneous SM differentiation upon spreading/elongation in culture Yang et al., 1998 Yang et al., , 1999 . We took advantage of their myogenic differentiation to generate a PCR-based cDNA library of undifferentiated mesenchymal cells subtracted with cDNA from their SM-differentiating counterparts. The purpose of this study was to identify potential suppressors of SM myogenesis. Among the genes highly expressed in undifferentiated cells heterogeneous nuclear ribonucleoprotein-H (hnRNP-H) was a gene whose expression dropped signi®cantly during the ®rst hours of SM myogenesis.
The heterogeneous ribonucleoproteins (hnRNPs) are a family of more than 20 members designated with letters from A to U (Krecic and Swanson, 1999; Siomi and Dreyfuss, 1997) . These proteins are characterized by having a modular structure that includes one or more RNA-binding domains together with one or more auxiliary domains that may mediate protein±protein interactions. hnRNPs were traditionally known for their role in pre-mRNA metabolism. However, it is now apparent that some hnRNPs bind to and regulate mature mRNA (Shih and Claffey, 1999) , function as transcription factors (Chen et al., 1998) or act by binding to proteins (Schullery et al., 1999) . hnRNP-H, along with hnRNP-H H , hnRNP-F and hnRNP-2H9 constitute a subfamily of hnRNPs with slightly different structure in the RNA recognition motifs (Honore et al., 1995; Mahe et al., 1997; Matunis et al., 1994) . Previous immunohistochemical studies indicated that hnRNP-H has an exclusive nuclear localization and is expressed in high levels by most mature cell types (Honore et al., 1999) . These same studies, however, showed low or no hnRNP-H immunodetection in visceral SM cell subpopulations.
hnRNP-H is one of the lesser known members of the hnRNP family, and only recently have some clues emerged as to its biological function. hnRNP-H has been shown to control the alternative splicing of at least two pre-mRNAs in a cell type-speci®c manner (Chen et al., 1999; Chou et al., 1999) : c-src pre-mRNA in neural cells (Chou et al., 1999) and b-tropomyosin pre-mRNA in striated muscle cells (Chen et al., 1999) .
Here we show that hnRNP-H is highly expressed in undifferentiated mouse embryonic mesenchymal cells and its expression rapidly decreases in mesenchymal cells undergoing SM differentiation. Furthermore, we show that antisense inhibition of hnRNP-H synthesis increases bronchial SM differentiation, whereas its overexpression has the opposite effect. These novel ®ndings underscore the importance of hnRNP-H in visceral myogenesis and suggest that the latter may be induced in part by a decrease in hnRNP-H levels.
Results

hnRNP-H expression decreases during the ®rst hours of SM differentiation
We generated a PCR-based cDNA subtracted library to search for potential suppressors of SM myogenesis. cDNA isolated from undifferentiated mesenchymal cells was subtracted with cDNA from mesenchymal cells undergoing SM myogenesis as described in Section 4. Screening of 300 transformed colonies indicated that hnRNP-H was one of the cDNAs signi®cantly more abundant in undifferentiated cells than SM-differentiated cells. hnRNP-H was identi®ed in four out of 32 clones that showed differential expression by dot blot hybridization. Northern blot, RT-PCR (data not shown) and immunoblot analysis con®rmed the differential expression of hnRNP-H in mesenchymal cells undergoing SM differentiation in culture (Fig. 1) . One hour after the undifferentiated mesenchymal cells were plated, hnRNP-H mRNA and protein levels were high, but decreased signi®-cantly during the ®rst 18 h in culture (Fig. 1A,B) . Our previous studies demonstrated that during this time the cells undergo spontaneous SM differentiation if allowed to spread Yang et al., 1998 Yang et al., , 1999 . During the next 3 days in culture hnRNP-H levels showed an additional mild decrease (data not shown). Lung epithelial cells isolated in parallel and maintained under the same culture conditions did not show oscillations in hnRNP-H expression (Fig. 1C) .
Northern blot and immunohistochemistry con®rmed the differential expression of hnRNP-H in vivo (Fig. 2) . Northern blots were done using whole embryonic organs prior to (E11) and 48 h after (E13) the onset of visceral myogenesis. The decrease in hnRNP-H expression was proportional to the amount of visceral SM development in the organs. Thus, intestine, a highly muscular organ, showed the largest decrease in hnRNP-H message, followed by lung, which produces intermediate levels of visceral SM. Kidney and liver, which contain essentially no visceral SM, showed no changes in hnRNP-H mRNA ( Fig. 2A) . Immunohistochemical studies con®rmed the high expression of hnRNP-H in undifferentiated mesenchymal and epithelial cells (Fig. 2B, D, arrow) , its decrease or disappearance in mature visceral SM cells (Fig. 2C ,E, arrow) and the lack of change in other cell types such as bronchial and colonic epithelial cells (Fig. 2E ,F, respectively). hnRNP-H was detected at high levels in the nuclei of skeletal and cardiac striated muscle and the immunostaining was comparatively less intense in vascular SM (Fig. 2G ).
SM myogenesis is altered by hnRNP-H levels
We conducted functional studies to determine the potential involvement of hnRNP-H in the regulation of SM myogenesis. Two oligodeoxynucleotides (ODNs) both including sequences complementary to the initiation codon were initially tested for their ability to downregulate hnRNP-H expression. One of them was 22-mer long and was complementary to nucleotides 66±87 and the other was 19-mer long and was complementary to nucleotides 77±95. The mesenchymal cells were transfected with the ODNs for 5 h, starting right after cell attachment was completed, and were evaluated for hnRNP-H levels 18 h later. Only the 19-mer nucleotide proved to be functionally active (Fig. 3 ). This antisense ODN signi®cantly reduced hnRNP-H mRNA and protein levels in SM-differentiating embryonic mesenchymal cells, whereas a control ODN consisting of the scrambled sequence had no effect (Fig. 3A, upper, lower, immunoblot) . The antisense ODN did not affect the synthesis of hnRNP-F (data not shown) or hnRNP-E (Fig. 3A, lower) , both members of the RNP family. Immunoblot analysis showed that the ODN-induced inhibition of hnRNP-H levels resulted in increased synthesis of SM-speci®c proteins, including SM a-actin, desmin and SM myosin, but did not affect glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels (Fig. 3B) . The increase in SM-speci®c gene expression was observed in all cells in culture, as indicated by immunostaining for SM myosin (Fig. 3C) .
A hnRNP-H antisense cDNA plasmid was also effective in decreasing hnRNP-H levels, as indicated by immunoblot analysis (Fig. 4A, upper) . As observed with the antisense ODN, inhibition of hnRNP-H by antisense RNA also resulted in enhanced SM protein expression (Fig. 4A , lower). Overexpression of hnRNP-H had the opposite effect resulting in a decrease in SM a-actin, desmin and SM myosin (Fig. 4B ). This experimental approach does not allow for determination of transfection ef®ciency. However, studies using hemaglutinin-tagged plasmid constructs unrelated to hnRNP-H indicated that approximately 30±35% of the cells in our primary cultures are transfected (S. Beqaj and L. Schuger, unpublished data).
hnRNP-H inhibition in embryonic lung explants stimulated bronchial SM myogenesis
Immunohistochemical studies of whole tissue mounts showed that lungs isolated from E11 embryos (before the onset of SM myogenesis) and cultured for 48 h untreated, in the presence of vehicle alone (data not shown) or in the presence of a control ODN, had only proximal bronchial SM development (Fig. 5A,B) , whereas lungs exposed to hnRNP-H antisense ODN had the entire airways covered by bronchial muscle (Fig. 5C) . Immunoblots con®rmed the ODN-induced reduction in hnRNP-H and the increment in SM a-actin as well as desmin in lungs exposed to hnRNP-H antisense ODN compared to controls (Fig. 5D) . A minimal increase in the number of airway terminal buds was observed in lung explants exposed to antisense ODN compared to controls (untreated, 12^4, 10 lungs; scrambled, 13^3, 10 lungs; antisense ODN, 15^3, 12 lungs).
Discussion
Although the onset and embryonic progression of visceral myogenesis are well documented, the molecular mechan- isms that control this process remain poorly understood. To obtain new insight into the process of myogenesis we generated a subtracted cDNA library enriched for potential suppressors of SM-speci®c gene expression. One of the candidates identi®ed was hnRNP-H, a nuclear-restricted hnRNP that recently has been shown to participate in premRNA alternative splicing (Chen et al., 1999; Chou et al., 1999) . Our studies showed that hnRNP-H is highly and steadily expressed by embryonic and mature tissues, however its expression rapidly decreases in mesenchymal cells undergoing SM differentiation. Once the myogenic process is completed, hnRNP-H expression remains low and the protein eventually disappears from numerous adult SM cells. This is consistent with previous studies showing little or no hnRNP-H immunodetection in human visceral SM cells (Honore et al., 1999) . Altogether, these ®ndings are consistent with a potential role of hnRNP-H in the suppression of SM myogenesis. Functional studies indeed demonstrated that high hnRNP-H levels prevent SM development. Inhibition of hnRNP-H synthesis by two different antisense strategies resulted in upregulation of SM-speci®c gene expression in embryonic mesenchymal cells undergoing myogenic differentiation, whereas hnRNP-H overexpression had the opposite effect.
Bronchial SM originates by differentiation of local peribronchial mesenchymal cells that by mid-gestation begin to express SM-related proteins in a proximal to distal fashion (Li et al., 1996; McHugh, 1995; Mitchell et al., 1990; Roman and McDonald, 1992; Ruzicka and Schwartz, 1988; Sawtell and Lessard, 1989 ). Here we found that exposure of embryonic lung explants to hnRNP-H antisense ODN signi®cantly accelerated peribronchial SM differentiation, con®rming the effect of hnRNP-H in a more physiological context. Interestingly, in cell cultures, hnRNP-H antisense ODN stimulated SM myosin expression in all the cells, as indicated by the general increase in SM myosin immunoreactivity shown in Fig. 3C . However, in organ cultures, exposure to hnRNP-H antisense ODN resulted in the myogenic differentiation of peribronchial mesenchymal cells only. Previous studies using FITC-tagged ODNs demonstrated that ODN penetration into lung explants is fast, diffuse and homogeneous (Zhang et al., 1999) . Therefore, it is unlikely that the induction of peribronchial myogenesis in lung explants was due to a concentration of ODN around airways. Although a subtly uneven ODN distribution cannot be completely excluded, we believe that the differences between isolated mesenchymal cells and the same cells within the organ underscore the multiple and complex tissue regulatory mechanisms that prevent aberrant SM formation in vivo.
These studies indicated a role for hnRNP-H in the control of visceral myogenesis. hnRNP-H is one of the less known members of the hnRNP family and only two recent studies delve into its biological function. It has been recently shown that hnRNP-H regulates the alternative splicing of c-src premRNA in neural cells (Chou et al., 1999) and of b-tropomyosin in striated muscle cells (Chen et al., 1999) . Regarding b-tropomyosin, Chen et al. (1999) demonstrated that binding of hnRNP-H to an exonic splicing silencer of btropomyosin pre-mRNA represses splicing of exon 7 in the latter, resulting in the synthesis of non-muscular b-tropomyosin. In contrast, blocking of hnRNP-H with antibodies or hnRNP-H depletion causes the exclusion of this exon and the production of muscle b-tropomyosin. These studies therefore suggested a role for hnRNP-H in the inhibition of striated muscle phenotype. Similarly, in the case of SM myogenesis a decrease in hnRNP-H could change the alternative splicing of cytoskeletal proteins in favor of SMspeci®c isoforms. However, our studies demonstrated that hnRNP-H regulates expression of SM proteins such as SM a-actin and desmin, which are not generated by alternative splicing. This suggests that hnRNP-H acts upon a broader range of muscle-speci®c proteins and probably at a higher level of gene expression regulation.
Among the various possibilities, hnRNP-H may regulate the alternative splicing of serum response factor (SRF) premRNA between SRF and its recently identi®ed dominant negative isoforms (Belaguli et al., 1999; Kemp and Metcalfe, 2000; Yang et al., 2000) . SRF is a well established myogenic transcription factor known to bind to the promoter regions of muscle-speci®c proteins and directly stimulate their transcription (Sobue et al., 1999) , whereas its two isoforms have the opposite effect (Belaguli et al., 1999;  Yang et al., 2000) . Other myogenic transcription factors generated by pre-mRNA alternative splicing, including isoforms of GATA-6 (Brewer et al., 1999) , LIM-1 (Brown et al., 1999) , Id1 (Springhorn et al., 1994) and ITF-2 (Skerjanc et al., 1996) , may also be regulated by hnRNP-H. Some of them have opposite effects over myogenesis (Skerjanc et al., 1996; Springhorn et al., 1994) and therefore may represent potential mediators of the hnRNP-H effect. Furthermore, hnRNP-H may affect splicing events occurring at different stages of SM differentiation. Altogether our ®nd-ings and the previous work by Chen et al. (1999) seem to support this possibility.
In summary, we have shown that embryonic mesenchymal cells express high levels of hnRNP-H and that a decrease in hnRNP-H is required for their differentiation into SM cells. These new ®ndings underscore an important role for hnRNP-H in the regulation of SM myogenesis.
Materials and methods
Cell and organ cultures
Crl: CD-1 (ICR) BR mice (Charles River, Wilmington, MA) were mated and the day of ®nding a vaginal plug was designated as day zero of embryonic development. Undifferentiated mesenchymal cells were isolated by differential plating from E11 intestine and lung (Schuger et al., 1993) . In addition, undifferentiated mesenchymal and epithelial cells were isolated from E12 lung by microdissection followed by trypsinization as previously described (Yang et al., 1998) . The cells were cultured for up to 5 days in minimal essential medium (Gibco BRL, Grand Island, NY) with 10% fetal bovine serum (Irvine Scienti®c, Santa Ana, CA) as previously described (Schuger et al., 1993) . Whole lungs microdissected from E11 mouse embryos were Embryonic lung explants were isolated from E11 embryos (prior to the onset of SM) and cultured for 48 h untreated (A) or in the presence of hnRNP-H scrambled ODN (B) or hnRNP-H antisense ODN (C). The explants were immunostained for SM a-actin as whole mounts to visualize the entire bronchial SM (¯uorescent green). Some proximal SM is identi®ed in the control explant (A,B, arrows), whereas the explant exposed to hnRNP-H antisense ODN shows highly developed proximal and distal bronchial muscle (C, arrows). (D) Immunoblots of lung organ cultures treated as in (B,C) or with vehicle alone and lysed at the end of the culture period. These studies con®rmed the immunohistochemical ®ndings by showing an ODN-induced decrease in hnRNP-H (1.9-fold) with a concomitant increase in SM a-actin and desmin (2.4-fold each). cultured at the air-medium interface on the upper surface of polycarbonate membrane inserts in a serum free-de®ned medium, BGJb (Gibco) (Schuger et al., 1997) .
Construction of libraries and subtracted probe
Undifferentiated mesenchymal cells were cultured for either 1 or 18 h, the ®rst time point representing undifferentiated embryonic mesenchymal cells and the second representing cells undergoing SM differentiation Yang et al., 1998 Yang et al., , 1999 . The mRNA from the two cultures was ampli®ed using the SMART w cDNA synthesis kit (Clontech, Palo Alto, CA) and PCR-Select w (Clontech) was then used for subtractive hybridization. Brie¯y, two pools of RsaI-digested cDNA from undifferentiated cells were used as a tester and ligated to two different oligonucleotide adapters. RsaI-digested cDNA from differentiated SM cells was used as a driver without adapters. Two hybridizations were performed between the tester population and excess driver. Only the cDNAs with different adapters at both ends were PCR-ampli®ed and they produced a pool of cDNA fragments more abundant in the undifferentiated than in the differentiated cells. The subtracted cDNAs were cloned into a pGEM-T vector (Promega, Madison, WI) and transformed into E. coli. Three hundred transformed colonies were selected randomly for screening. Dot-blot hybridization was performed with 32 P-labeled cDNA forwardand reverse-subtracted cDNAs as probes. The reversesubtracted probe was made by subtractive hybridization performed with the original tester cDNA as a driver and the driver cDNA as a tester.
RNA analysis
Total RNA was extracted with TRIzol reagent (Gibco) ) from E11 and E13 gut, lung, kidney and liver and from 1-and 18-h-old mesenchymal and epithelial cell cultures. Northern blots were performed according to standard protocols (Schuger et al., 1992 ) using the same hnRNP-H cDNA fragment as for library screens. A control [ 32 P]cDNA fragment complementary to GAPDH was used to reprobe the membranes. Autoradiograms were quanti®ed using the software Quantity OneRad) at a 1:3000 dilution were used as secondary antibody. After electrophoretic transfer, the nitrocellulose membranes were immunostained for hnRNP-H and successively striped and re-immunostained for hnRNP-E, one of the SM-related proteins and GAPDH. The bands were detected by chemiluminescence using a commercial kit (Amersham Life Science, Arlington Heights, IL) according to the manufacturer's instructions. Protein blots were quanti®ed using Quantity One w software.
Immunohistochemistry
Cell and whole organ cultures were respectively immunostained for SM myosin and SM a-actin as previously described (Yang et al., 1998; Zhang et al., 1999) . Antibodies to SM myosin were used at a concentration of 20 mg/ml and antibodies against SM a-actin were used at a concentration of 1 mg/ml. After incubation with the ®rst antibody, the cells and tissues were exposed to a 1:50 dilution of either biotinconjugated goat anti-mouse or biotin-conjugated anti-rabbit IgG (Sigma, St. Louis, MO). Cell staining was completed using a commercial peroxidase/anti-peroxidase kit following the manufacturer's instructions (ABC kit from Vector, Burlingame, CA). Slides were counterstained with hematoxylin. Organ culture staining was completed using a 1:50 dilution of FITC-conjugated avidin (Sigma).
